4CPS-095 Drug-drug interactions among hepatitis c patients treated with direct-acting antivirals

BACKGROUND: Interferon-free combination direct-acting antivirals (DAAs) regimens have improved tolerability and efficacy for HCV-infected patients but it is necesary to check drug-drug interactions (DDIs) because they have the potential to cause toxicity or loss of efficacy to treat HCV. PURPOSE: To...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur J Hosp Pharm
Main Authors: Vargas, B Rodriguez, Garcia, E Matilla, Fernández, C Apezteguía, Sanz, MP Bautista, del Hoyo, L Esteban, Garcia, I Santaolalla, Diaz, R Moreno
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Group 2018
Assuntos:
Section 4: Clinical pharmacy services
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535731/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.186
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados